Clinical Trials Directory

Trials / Completed

CompletedNCT04297813

Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting

Randomized Controlled Clinical Trial to Assess the Efficacy of a Combination of Autologous Mesenchymal Stem Cells and Biomaterial in Jaw Bone Regeneration Prior to Dental Implant Placement in Comparison to Standard Autologous Bone Grafting

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
48 (actual)
Sponsor
University of Bergen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

A randomized controlled clinical multi center trial to assess the efficacy of a combination of autologous mesenchymal stem cells and biomaterial in jaw bone regeneration prior to dental implant placement in comparison to standard autologous bone block grafting.

Detailed description

A phase III multi center clinical trial, randomized and controlled.The study subject is lacking one or more sheet behind the canine in the upper or lower jaw, and the alveolar ridge is too narrow to place a dental implant. The test objects will have augmentation using autologous mesenchymal stromal cells and a biomaterial, biphasic Calcium Phosphate. The control is the traditional bone block from the ramus.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTAdvanced medicinal Therapy (MSC combined with biomaterial)Augmentation of alveolar ridge with MSC and biomaterial
PROCEDUREAutologous bone graftAugmentation of the alveolar ridge with bone graft

Timeline

Start date
2020-03-12
Primary completion
2023-07-31
Completion
2024-07-31
First posted
2020-03-06
Last updated
2025-06-29

Locations

6 sites across 4 countries: Denmark, France, Norway, Spain

Source: ClinicalTrials.gov record NCT04297813. Inclusion in this directory is not an endorsement.